Theragen Etex Co Ltd

066700

Company Profile

  • Business description

    Theragen Etex Co Ltd is a Korea-based company mainly engaged in the manufacturing and selling of finished pharmaceutical products and providing genome sequencing services. It also provides healthcare services. The company's operating segments include its Pharmaceutical business and the Healthcare and Genome Analysis Business. A majority of its revenue is generated from the Pharmaceutical Business which involves the manufacturing and sales of specialized and general medicine along with new drug research and development. The Healthcare and Genome Analysis Business involves DNA sequence analysis, RNA mutation genome analysis and decoding, and the distribution of non-prescription drugs for healthcare purposes. Geographically, the company derives its key revenue from the domestic market.

  • Contact

    58, Sandan-ro 68-gil
    Danwon-gu, Gyeonggi-do
    Ansan-si
    KOR

    T: +82 234637111

    http://www.theragenetex.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    213

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries7,969.70116.001.48%
CAC 407,104.8021.22-0.30%
DAX 4020,374.10188.63-0.92%
Dow JONES (US)40,212.71619.051.56%
FTSE 1007,964.1850.930.64%
HKSE21,419.59504.902.41%
NASDAQ16,724.46337.142.06%
Nikkei 22534,171.30585.721.74%
NZX 50 Index12,153.64134.511.12%
S&P 5005,363.3695.311.81%
S&P/ASX 2007,759.80113.301.48%
SSE Composite Index3,266.1327.900.86%

Market Movers